Doctor profile · Federal record
Dr. Rohan Ahluwalia
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Santa Cruz, CA
- NPI 1053632356
- Accepts Medicare
- 16 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2850 Commercial Xing
Santa Cruz, CA 950651702
(831) 460-7555 - Mailing address
-
325 Distel Cir
Los Altos, CA 940221408
Credentials & registration
- NPI registered
- June 2010 — 16 yrs on file
- Profile last updated
- August 9, 2019
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A141525
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1053632356. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
90,720
Distinct HCPCS
10
Medicare allowed
$2,253,076
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 13,100 | 22 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 10,950 | 27 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,540 | 13 | $48 | |
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 9,480 | 14 | $0 | |
J3380 |
Injection, vedolizumab, 1 mg | 9,300 | 11 | $22 | |
J9267 |
Injection, paclitaxel, 1 mg | 7,884 | 13 | $0 | |
J9030 |
Bcg live intravesical instillation, 1 mg | 5,450 | 43 | $3 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 3,750 | 16 | $13 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,725 | 16 | $42 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 2,600 | 13 | $7 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 1,891. This provider delivers 48× the peer median.Open Payments
Industry payments received
All-time total
$481
Transactions
19
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Celgene Corporation | 4 | $84.03 | |
| Janssen Biotech, Inc. | 2 | $46.41 | |
| Amgen Inc. | 1 | $39.61 | |
| Sumitomo Pharma America, Inc. | 1 | $35.35 | |
| PUMA BIOTECHNOLOGY, INC. | 1 | $29.39 | |
| ABBVIE INC. | 1 | $29.21 | |
| Novartis Pharmaceuticals Corporation | 1 | $28.84 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $25.34 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $24.01 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24.01 | |
| PFIZER INC. | 1 | $23.58 | |
| Daiichi Sankyo Inc. | 1 | $23.49 | |
| SOBI, INC | 1 | $23.13 | |
| Merck Sharp & Dohme LLC | 1 | $22.82 | |
| ARRAY BIOPHARMA INC | 1 | $22.09 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
683
Patients
184
Total drug cost
$766,151
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 157 | 46 | $5,925 |
| Abiraterone Acetate | Generic | 90 | 14 | $94,183 |
| Prednisone | Generic | 78 | 21 | $933 |
| Acyclovir | Generic | 54 | 15 | $1,468 |
| Prochlorperazine Maleate | Generic | 52 | 36 | $546 |
| Ondansetron Hcl | Generic | 49 | 30 | $513 |
| Eliquis (Apixaban) | Brand | 40 | 0 | $28,846 |
| Dexamethasone | Generic | 33 | 22 | $574 |
| Lorazepam | Generic | 32 | 0 | $160 |
| Lenalidomide | Generic | 22 | 0 | $264,308 |
Hospital affiliations
Frequently asked questions
What is Dr. Rohan Ahluwalia's medical specialty?
Dr. Rohan Ahluwalia practices Hematology & Oncology Physician in Santa Cruz, CA.
Where does Dr. Rohan Ahluwalia practice?
Dr. Rohan Ahluwalia practices at 2850 Commercial Xing, Santa Cruz, CA 950651702. Office phone: 8314607555.
What is Dr. Rohan Ahluwalia's NPI?
Dr. Rohan Ahluwalia's National Provider Identifier (NPI) is 1053632356, issued by NPPES.
Does Dr. Rohan Ahluwalia accept Medicare assignment?
Yes. Dr. Rohan Ahluwalia accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rohan Ahluwalia commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.